For patients on continuous medication for pain relief in late-stage illness, the FDA has approved methylnaltrexone bromide (Relistor) injection for treatment of opioid-induced constipation. References and Resources FDA…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses the user experience of hospital IT systems. For the Bill Crounse, MD blog visit: HealthBlog For more…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses his views on the lack of healthcare IT in the US. For the Bill Crounse, MD blog…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses his thoughts on the…
In a phase III, randomized, open-labeled, noninferiority study that compared clinical cure of ventilator-associated pneumonia with doripenem IV with two different does of imipenem IV, length of stay…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his thoughts on…
Jeffrey M. Lipton, MD, Ph.D, Chief Pediatric Hematology/Oncology and Stem Cell Transplantation, Schneider Children’s Hospital, and Professor of Pediatrics at Albert Einstein College of Medicine, discusses cord blood.…
A tablet that combines sumatriptan and naproxen (Treximet) has been approved by the FDA for treatment of migraine with and without aura. References and Resources FDA Sponsored by…
An investigational compound for chronic plaque psoriasis has shown to be safe and effective. In an industry-sponsored phase III trial, the calcineurin inhibitor ISA247 significantly reduced the extent…
Oded Preis, MD, FAAP, Associate Clinical Professor of Pediatrics, SUNY Downstate Brooklyn, discusses who he believes should be the payee for vaccines. Submitted by: Dr. Melvin Koplow
